Characterizing the Pathogenic, Genomic, and Chemical Traits of Aspergillus fischeri, a Close Relative of the Major Human Fungal Pathogen Aspergillus fumigatus by NC DOCKS at The University of North Carolina at Greensboro et al.
Characterizing the Pathogenic, Genomic, and Chemical Traits of Aspergillus fischeri, a 
Close Relative of the Major Human Fungal Pathogen Aspergillus fumigatus 
By: Matthew E. Mead, Sonja L. Knowles, Huzefa A. Raja, Sarah R. Beattie, Caitlin H. 
Kowalski, Jacob L. Steenwyk, Lilian P. Silva, Jessica Chiaratto, Laure N. A. Ries, Gustavo H. 
Goldman, Robert A. Cramer, Nicholas H. Oberlies, Antonis Rokas 
Mead, M.E., Knowles, S.L., Raja, H.A., Beattie, S.R., Kowalski, C.H., Steenwyk, J.L., Silva, 
L.P., Chiaratto, J., Ries, L.N.A., Goldman, G.H., Cramer, R.A., Oberlies, N.H., & Rokas, A. 
(2019). Characterizing the pathogenic, genomic, and chemical traits of Aspergillus fischeri, a 
close relative of the major human fungal pathogen Aspergillus fumigatus. mSphere, 4(1), 
e00018-00019. doi: 10.1128/mSphere.00018-19 
Made available courtesy of American Society for Microbiology: 
http://dx.doi.org/10.1128/mSphere.00018-19  
 © The Authors. Published under a Creative Commons Attribution 4.0 International 
License (CC BY 4.0); https://creativecommons.org/licenses/by/4.0/  
Abstract: 
Aspergillus fischeri is closely related to Aspergillus fumigatus, the major cause of invasive mold 
infections. Even though A. fischeri is commonly found in diverse environments, including 
hospitals, it rarely causes invasive disease. Why A. fischeri causes less human disease than A. 
fumigatus is unclear. A comparison of A. fischeri and A. fumigatus for pathogenic, genomic, and 
secondary metabolic traits revealed multiple differences in pathogenesis-related phenotypes. We 
observed that A. fischeri NRRL 181 is less virulent than A. fumigatus strain CEA10 in multiple 
animal models of disease, grows slower in low-oxygen environments, and is more sensitive to 
oxidative stress. Strikingly, the observed differences for some traits are of the same order of 
magnitude as those previously reported between A. fumigatus strains. In contrast, similar to what 
has previously been reported, the two species exhibit high genomic similarity; ∼90% of the A. 
fumigatus proteome is conserved in A. fischeri, including 48/49 genes known to be involved in 
A. fumigatus virulence. However, only 10/33 A. fumigatus biosynthetic gene clusters (BGCs) 
likely involved in secondary metabolite production are conserved in A. fischeri and only 13/48 
A. fischeri BGCs are conserved in A. fumigatus. Detailed chemical characterization of A. 
fischeri cultures grown on multiple substrates identified multiple secondary metabolites, 
including two new compounds and one never before isolated as a natural product. Additionally, 
an A. fischeri deletion mutant of laeA, a master regulator of secondary metabolism, produced 
fewer secondary metabolites and in lower quantities, suggesting that regulation of secondary 
metabolism is at least partially conserved. These results suggest that the nonpathogenic A. 
fischeri possesses many of the genes important for A. fumigatus pathogenicity but is divergent 
with respect to its ability to thrive under host-relevant conditions and its secondary metabolism. 
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ABSTRACT Aspergillus fischeri is closely related to Aspergillus fumigatus, the major
cause of invasive mold infections. Even though A. fischeri is commonly found in di-
verse environments, including hospitals, it rarely causes invasive disease. Why A. fis-
cheri causes less human disease than A. fumigatus is unclear. A comparison of A. fis-
cheri and A. fumigatus for pathogenic, genomic, and secondary metabolic traits
revealed multiple differences in pathogenesis-related phenotypes. We observed that
A. fischeri NRRL 181 is less virulent than A. fumigatus strain CEA10 in multiple animal
models of disease, grows slower in low-oxygen environments, and is more sensitive
to oxidative stress. Strikingly, the observed differences for some traits are of the
same order of magnitude as those previously reported between A. fumigatus strains.
In contrast, similar to what has previously been reported, the two species exhibit
high genomic similarity; 90% of the A. fumigatus proteome is conserved in A. fisch-
eri, including 48/49 genes known to be involved in A. fumigatus virulence. However,
only 10/33 A. fumigatus biosynthetic gene clusters (BGCs) likely involved in second-
ary metabolite production are conserved in A. fischeri and only 13/48 A. fischeri BGCs
are conserved in A. fumigatus. Detailed chemical characterization of A. fischeri cul-
tures grown on multiple substrates identified multiple secondary metabolites, includ-
ing two new compounds and one never before isolated as a natural product. Addi-
tionally, an A. fischeri deletion mutant of laeA, a master regulator of secondary
metabolism, produced fewer secondary metabolites and in lower quantities, sug-
gesting that regulation of secondary metabolism is at least partially conserved.
These results suggest that the nonpathogenic A. fischeri possesses many of the
genes important for A. fumigatus pathogenicity but is divergent with respect to its
ability to thrive under host-relevant conditions and its secondary metabolism.
IMPORTANCE Aspergillus fumigatus is the primary cause of aspergillosis, a devastat-
ing ensemble of diseases associated with severe morbidity and mortality worldwide.
A. fischeri is a close relative of A. fumigatus but is not generally observed to cause
human disease. To gain insights into the underlying causes of this remarkable differ-
ence in pathogenicity, we compared two representative strains (one from each spe-
cies) for a range of pathogenesis-relevant biological and chemical characteristics. We
found that disease progression in multiple A. fischeri mouse models was slower and
caused less mortality than A. fumigatus. Remarkably, the observed differences be-
tween A. fischeri and A. fumigatus strains examined here closely resembled those
previously described for two commonly studied A. fumigatus strains, AF293 and
CEA10. A. fischeri and A. fumigatus exhibited different growth profiles when placed
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in a range of stress-inducing conditions encountered during infection, such as low
levels of oxygen and the presence of chemicals that induce the production of reac-
tive oxygen species. We also found that the vast majority of A. fumigatus genes
known to be involved in virulence are conserved in A. fischeri, whereas the two spe-
cies differ significantly in their secondary metabolic pathways. These similarities and
differences that we report here are the first step toward understanding the evolu-
tionary origin of a major fungal pathogen.
KEYWORDS comparative genomics, evolution of virulence, fungal pathogenesis,
laeA, secondary metabolism, specialized metabolism
Aspergillosis is a major cause of human morbidity and mortality, resulting in over200,000 life-threatening infections each year worldwide, and is primarily caused by
the filamentous fungus Aspergillus fumigatus (1). Multiple virulence traits related to
invasive aspergillosis (IA) are known for A. fumigatus, including growth at human body
temperature and under low-oxygen conditions, the ability to acquire micronutrients
such as iron and zinc in limiting environments, and the production of a diverse set of
secondary metabolites (1).
Growth at human body temperature is a key trait for the survival of A. fumigatus
inside mammalian hosts and may have arisen through adaptation to the warm tem-
peratures present in decaying compost piles, one of the organism’s ecological niches
(2–4). The primary route of A. fumigatus colonization and infection is through the lung,
where oxygen levels have been observed to be as low as 2/3 of atmospheric pressure
during infection. A successful response to this hypoxic environment is required for
fungal pathogenesis (5, 6). Moreover, A. fumigatus produces a diverse set of small,
bioactive molecules, known as secondary metabolites, which are biosynthesized in
pathways that are often encoded by biosynthetic gene clusters (BGCs) (7). Some of
these secondary metabolites and their regulators have been shown to contribute to
disease in mouse models (8–10). Furthermore, a master regulator of secondary metab-
olism, laeA, is required for full virulence in IA mouse model studies (11, 12).
Species closely related to A. fumigatus are also capable of causing disease, but they
are rarely observed in the clinic (1, 13–15). For example, Aspergillus fischeri is the closest
evolutionary relative to A. fumigatus for which a genome has been sequenced (16, 17),
but it is rarely reported to cause human disease (1). Recent evolutionary genomic
analyses suggest that A. fischeri and A. fumigatus last shared a common ancestor
approximately 4 million years ago (95% credible interval: 2 to 7 million years ago) (17).
Why A. fischeri-mediated disease is less common than A. fumigatus-mediated disease
remains an open question. Non-mutually exclusive possibilities include differences in
ecological abundance, lack of species-level diagnosis of disease-causing strains in the
clinic, and innate differences in pathogenicity and virulence between the two species.
Previous studies have suggested that the difference in the frequencies with which
the two species cause disease is unlikely to be solely due to ecological factors, as both
can be isolated from a variety of locales, including soils, fruits, and hospitals (18–20). For
example, approximately 2% of the fungi isolated from the respiratory intensive care
unit at Beijing Hospital were A. fischeri compared to approximately 23% of fungal
species identified as A. fumigatus (20). While A. fischeri is easily isolated from a variety
of environments, only a few cases of human infections have been reported (21–24).
Furthermore, numerous recent epidemiological studies from multiple countries that
used state-of-the-art molecular typing methods were able to identify several rarely
isolated pathogenic species closely related to A. fumigatus, such as Aspergillus lentulus
and Aspergillus udagawae, as the source of 10 to 15% of human infections but did not
identify A. fischeri in any patient sample (13, 14, 25–27).
If ecological factors and lack of precision in species identification do not convinc-
ingly explain why A. fischeri is nonpathogenic and A. fumigatus is pathogenic, other
factors must be responsible. An initial genomic comparison between strains of A.
fumigatus, A. fischeri, and the more distantly related Aspergillus clavatus identified 818
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genes that were A. fumigatus specific (16). These genes were enriched for functions
associated with carbohydrate transport and catabolism, secondary metabolite biosyn-
thesis, and detoxification (16), raising the possibility that the observed differences in
pathogenicity observed between A. fischeri and A. fumigatus have a molecular basis.
To gain further insight into why A. fischeri-mediated disease is less abundant than A.
fumigatus-mediated disease, we took a multipronged approach to investigate pheno-
typic, genomic, and chemical differences between A. fischeri strain NRRL 181 and A.
fumigatus strain CEA10. We observed that while A. fischeri is able to cause fatal disease
in multiple animal models, its disease progression and response to multiple host-
relevant stresses are markedly reduced compared to A. fumigatus CEA10. We also found
that while the two organisms’ genomes are in general very similar, the sets of
secondary metabolite pathways in each of them exhibit a surprisingly low level of
overlap. Examination of the secondary metabolite profile of A. fischeri identified both
previously isolated and novel compounds. Finally, construction of a mutant A. fischeri
strain that lacked the laeA gene, a master regulator of secondary metabolism, and
examination of its chemical profile suggested that LaeA-mediated regulation of sec-
ondary metabolism in A. fischeri closely resembles that of A. fumigatus. These results
begin to reveal the molecular differences between A. fischeri and A. fumigatus related
to fungal pathogenesis and suggest that a functional evolutionary genomic compari-
son between pathogenic and nonpathogenic species closely related to A. fumigatus
harbors great promise for generating insights into the evolution of fungal disease.
RESULTS
A. fischeri is less virulent than A. fumigatus in multiple animal models of
invasive pulmonary aspergillosis (IPA). In contrast to A. fumigatus-mediated disease,
only a few cases of invasive fungal infections have been reported to be caused by A.
fischeri (21–24). Given this contrast, we utilized two immunologically distinct murine IPA
models to assess differences in pathogenicity and virulence between the two species.
In a leukopenic murine model, A. fischeri NRRL 181 was significantly less virulent than
A. fumigatus CEA10, in a dose-dependent manner (Fig. 1A). Using an inoculum of
1  105 conidia, A. fischeri was completely attenuated in virulence, with 100% murine
survival by day 15 post-fungal challenge. In contrast, inoculation with A. fumigatus
resulted in 100% murine mortality by day 15 (Fig. 1A). Using a higher dose (2  106) of
conidia, both strains caused 90% mortality by day 14; however, the disease progression
was markedly different. Eighty percent of mice inoculated with A. fumigatus succumbed
to infection by day 4, whereas in mice inoculated with A. fischeri, mortality started
occurring on day 5, and then one or two mice succumbed each day until day 14
(Fig. 1A). Thus, despite the similar overall mortality at higher fungal challenge doses, A.
fischeri is substantially less virulent than A. fumigatus in a leukopenic murine IPA model.
To better understand what is happening in vivo during disease progression with A.
fischeri NRRL 181 and A. fumigatus CEA10, we performed histological analyses on lungs
from the leukopenic model 3 days postinoculation. Histological sections were stained
with Gomori methenamine silver (GMS) to visualize fungal burden and with hematox-
ylin and eosin (H&E) stain to visualize host-related pathology (Fig. 1C). Leukopenic mice
inoculated with A. fumigatus had an overall greater number of fungal lesions per animal
than mice inoculated with A. fischeri. These A. fumigatus lesions contained a greater
amount of fungus, which coincided with increased tissue necrosis surrounding the
lesions. There was also a greater number of A. fumigatus lesions with fungi invading
from the larger airways into the lung parenchyma. Meanwhile, the A. fischeri lesions
were largely maintained within the larger airways. A striking difference between the
lesions caused by the two species was in the appearance of the hyphae of the two
species, where A. fischeri filaments were much shorter than those of A. fumigatus. We
hypothesize that in the leukopenic mouse, A. fischeri is unable to grow as well as A.
fumigatus, resulting in smaller and fewer fungal lesions, shorter fungal filaments, and
attenuation of virulence.
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As the patient population at risk for IA continues to change and grow (28), we next
tested a nonleukopenic, triamcinolone (steroid)-induced immune suppression model
and observed a significant reduction in virulence of A. fischeri compared to A. fumigatus
(P  0.0001 by log rank and Gehan-Breslow-Wilcoxon tests). All mice inoculated with
A. fumigatus succumbed to infection by day 4; however, similar to the leukopenic
model, mice inoculated with A. fischeri had significantly slower disease progression as
monitored by Kaplan-Meier analyses (Fig. 1B).
Histological analyses were also carried out on lungs from the steroid model 3 days
post-fungal inoculation (Fig. 1C). Overall, mice inoculated with A. fischeri in the steroid
model had similar numbers of fungal lesions as those inoculated with A. fumigatus, but
the lesions caused by the two species were phenotypically distinct (Fig. 1C). In larger
terminal bronchioles infected with A. fumigatus, there was greater fungal growth per
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FIG 1 A. fischeri is significantly less virulent than A. fumigatus in multiple murine models of invasive pulmonary aspergillosis. (A)
Cumulative survival of mice inoculated with 1  105 (gray) or 2  106 (black) conidia in a leukopenic model of IPA. For the inoculations
of 1  105 conidia, 10 mice were infected per group, and for the inoculations of 2  106 conidia, 12 mice were infected per group. For
each PBS control, 4 mice were inoculated. *, P  0.0098 by log rank test and P  0.0002 by Gehan-Breslow-Wilcoxon test. (B) Cumulative
survival of mice inoculated with 2  106 conidia in a steroid model of IPA. n  12/group, 4 for PBS. *, P  0.0001 by log rank and
Gehan-Breslow-Wilcoxon tests. (C) Histological sections from 3 days postinoculation in a leukopenic (left) and steroid (right) model of IPA,
stained with H&E and GMS. Images were acquired at 100. (D) Cumulative survival of G. mellonella larvae inoculated with 1  106 (gray)
or 1  109 (black) conidia. Ten larvae were used per condition in all assays. Survival curves for A. fischeri and A. fumigatus were significantly
different (P  0.003) in both log rank and Gehan-Breslow-Wilcoxon tests for both inocula.
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lesion, and the growth was observed throughout the bronchiole itself, extending well
into the lumen. These lesions were accompanied by substantial granulocytic inflam-
mation and obstructed the airways surrounding the hyphae (Fig. 1C). In the lesions
containing A. fischeri, the fungal growth was contained to the epithelial lining of the
bronchioles. This pattern of growth was accompanied by inflammation at the airway
epithelia, leaving the airway lumen largely unobstructed (Fig. 1C). The lack of airway
obstruction during A. fischeri infection and reduced inflammation may contribute to the
reduced virulence compared to A. fumigatus in this murine model.
Although the distribution of the fungal lesions varied, there was still significant
fungal growth in the steroid immunosuppressed mice infected with A. fischeri, sug-
gesting that A. fischeri is capable of growing within the immunocompromised murine
host. Indeed, we tested the growth rate of A. fischeri and A. fumigatus in lung
homogenate as a proxy for growth capability within the nutrient environment of the
host and observed no difference between the two strains (see Fig. S1 in the supple-
mental material). These experiments show that in multiple models of fungal disease, A.
fischeri is less virulent than A. fumigatus even though it is able to grow within the
immunocompromised murine lung.
We observed similar pathogenicity and virulence results when using the Galleria
mellonella insect larva model of aspergillosis (Fig. 1D). Both low (1  106 conidia)- and
high (1  109 conidia)-inoculum experiments showed significant differences between
the disease progression of A. fischeri (slower) and A. fumigatus (faster) in this insect
model of fungal pathogenicity.
Compared to A. fumigatus, A. fischeri differs in its response to several host-
relevant stresses. Our in vivo experiments suggested that the lower virulence of A.
fischeri is not the result of an inability to grow within the host per se. Therefore, we
hypothesized that A. fischeri is unable to mitigate stresses encountered in the host as
effectively as its close evolutionary relative A. fumigatus. Nutrient fluctuation is a stress
encountered in vivo during A. fumigatus infection (29), and to assess differences in
metabolic plasticity between the two species, we measured the two organisms’ growth
on media supplemented with glucose, fatty acids (Tween 80), or Casamino Acids.
Because low oxygen tension is a significant stress encountered during infection (5), and
recently, fitness in low oxygen has been correlated with virulence of A. fumigatus (30),
we measured growth of both species at 37°C under both normoxic (ambient air) and
hypoxia-inducing (0.2% O2, 5% CO2) conditions. In normoxia with glucose, fatty acids
(Tween 80), or Casamino Acids supplied as the carbon source, radial growth of A. fischeri
was reduced compared to A. fumigatus (Fig. 2). However, on rich media both organisms
grew equally well (Fig. 2). We also observed a lower growth rate of A. fischeri than A.
fumigatus in the first 16 h of culture in liquid media supplied with glucose at 37°C. At
30°C, A. fischeri grew the same as, or better than, A. fumigatus except on Tween 80,
where A. fumigatus had a slight advantage (Fig. S2). Also, A. fischeri grew substantially
worse than A. fumigatus at 44°C (Fig. S2), a temperature rarely observed in the patient
but easily observed in compost piles. To determine relative fitness in hypoxic liquid
environments, we measured the ratio of biomass in liquid culture in ambient air
(normoxia) versus hypoxic (0.2% O2, 5% CO2) conditions. A. fischeri showed significantly
lower fitness under hypoxic conditions, with about an 8.5-fold-lower biomass than A.
fumigatus (Fig. 3A). These data suggest that A. fischeri is less fit than A. fumigatus at 37°C
and under low-oxygen conditions, both of which have been shown to impact fungal
virulence.
Metabolic flexibility, or the ability for an organism to utilize multiple carbon sources
simultaneously, has been suggested to provide a fitness advantage to Candida albicans
during in vivo growth (31). Metabolic flexibility can be characterized using the glucose
analog 2-deoxyglucose (2-DG), in combination with an alternative carbon source
available in vivo, such as lactate. 2-DG triggers carbon catabolite repression, which
shuts down alternative carbon utilization pathways. However, in C. albicans this shut-
down is delayed and growth occurs on lactate with 2-DG (31, 32). We tested the
metabolic flexibility of both A. fumigatus and A. fischeri and observed that while both
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species can grow in the presence of 2-DG on lactate, the growth inhibition of A. fischeri
is higher (60%) than that of A. fumigatus (35%; Fig. 3B). Even under low-oxygen
conditions (5% and 2%), A. fumigatus maintains this metabolic flexibility except under
extremely low oxygen conditions (0.2%), whereas A. fischeri shows even greater inhi-
bition at all oxygen tensions of 5% or below. These data suggest that while both
species exhibit some level of metabolic flexibility, A. fumigatus appears more metabol-
ically flexible under a wider range of conditions than A. fischeri.
Next, we measured the susceptibility of A. fischeri to oxidative stress, cell wall stress,
and antifungal drugs as they are stresses that are encountered during infection and
treatment (33). Interestingly, we observed that A. fischeri is more resistant to the
intracellular oxidative stress agent menadione than A. fumigatus but more susceptible
to the external oxidative stress agent hydrogen peroxide (Fig. 3C and D). As the in vivo
levels of inflammation caused by the two species appeared different, we indirectly
tested for differences in cell wall pathogen-associated molecular patterns using the cell
wall-perturbing agents Congo red and calcofluor white. A. fumigatus was significantly
more resistant to both agents than A. fischeri (Fig. 3C), suggesting differences in the
response to cell wall stress or in the composition and organization of the cell wall
between the two species. These differences are likely important for host immune cell
recognition and interaction, which in turn influence pathology and disease outcome.
Last, A. fischeri showed enhanced resistance relative to A. fumigatus for three of the
four antifungal drugs tested (Table 1), consistent with previous experiments (34).
Overall, our phenotypic data show that the response of A. fischeri to host-related
stresses and antifungals is substantially different from that of A. fumigatus. Furthermore,
our results suggest that increased growth capability of A. fumigatus in low oxygen and
in high temperatures are two important attributes that likely contribute to its patho-
genic potential compared to A. fischeri.
The proteomes of A. fumigatus and A. fischeri are highly similar, but their
secondary metabolic pathways show substantial divergence. The large differences
in virulence and virulence-related traits we observed between A. fumigatus and A.
fischeri led us to investigate the genotypic differences that could be responsible. To
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FIG 2 A. fischeri is unable to thrive under suboptimal metabolic conditions at 37°C. A total of 1  103 conidia were point inoculated on
each plate, and then plates were incubated at 37°C in normoxia (N; 21% oxygen, 5% CO2) or hypoxia (H; 0.2% O2, 5% CO2); colony
diameter was measured every 24 h. Mean and SEM for triplicates. CAA, Casamino Acids; GMM, glucose minimal medium.
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describe the genomic similarities and differences between A. fumigatus and A. fischeri,
we determined how many orthologous proteins and how many species-specific pro-
teins were present in each genome using a reciprocal best BLAST hit approach (35). We
identified 8,737 proteins as being shared between the two species (Fig. S3), represent-
ing 88% and 84% of the A. fumigatus and A. fischeri proteomes, respectively, and 1,684
A. fischeri-specific proteins (16% of its proteome) and 1,189 A. fumigatus-specific
proteins (12% of its proteome). These results are similar to what had previously been
reported in an early analysis of the A. fischeri genome (16).
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FIG 3 A. fischeri is more susceptible to multiple host-relevant stresses than A. fumigatus. (A) Fitness ratio of A.
fumigatus or A. fischeri during hypoxic versus normoxic growth (measured as the dry weight of cultures). Data
represent mean and SEM for biological triplicates; ***, P  0.0006 by Student’s t test. (B) Growth inhibition of strains
grown on 1% lactate minimal medium with 0.1% 2-deoxyglucose (2-DG) under a range of low-oxygen conditions.
(C) A. fumigatus and A. fischeri were grown in the presence of the cell wall-perturbing agent Congo red (0.5 mg/ml),
the oxidative stressor menadione (20 M), or the chitin-perturbing agent calcofluor white (CFW; 25 g/ml). Plates
were grown for 96 h at 37°C and 5% CO2. For all plates except Congo red and its GMM control, 1  103 spores were
plated. For Congo red and the control GMM plate, 1  105 spores were plated. Student’s t test was performed, and
significance was as follows: *, P  0.05; **, P  0.01. (D) Strains were grown for 48 h at 37°C in liquid complete
medium supplemented with increasing concentrations of hydrogen peroxide.
TABLE 1 A. fischeri shows enhanced resistance relative to A. fumigatus for several
antifungal drugs
Strain
MIC of drug (g/ml)
MEC of
caspofungin (g/ml)Posaconazole Voriconazole Itraconazole
A. fumigatus 0.7 0.8 5 0.09
A. fischeri 2.4 4 24 0.06
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To narrow our search for genes that are absent in A. fischeri but are important for A.
fumigatus disease, we compiled a list of 49 A. fumigatus genes considered to be
involved in virulence (see Table S1 in the Figshare document at https://doi.org/10.6084/
m9.figshare.7149167) based on two previously published articles (36, 37) and extensive
literature searches of our own. We observed that all but one of these virulence-
associated genes were also present in A. fischeri, a surprising finding considering the
substantial differences observed between the two species in our animal models of
infection. The virulence-associated gene not present in A. fischeri is pesL (Afu6g12050),
a nonribosomal peptide synthase that is essential for the synthesis of the secondary
metabolite fumigaclavine C and required for virulence in the Galleria model of A.
fumigatus infection (38).
Since the only previously described A. fumigatus virulence-associated gene not
present in the A. fischeri genome (i.e., pesL) is involved in secondary metabolism and a
previous study suggested that secondary metabolism is not conserved between these
two species (39), we investigated the differences between the repertoire of secondary
metabolic pathways present in A. fumigatus and A. fischeri. Using the program antiS-
MASH (40), we identified 598 genes distributed among 33 BGCs in A. fumigatus (see
Table S2 in the Figshare document at https://doi.org/10.6084/m9.figshare.7149167) and
786 genes spread out over 48 BGCs in A. fischeri (see Table S3 in the Figshare document
at https://doi.org/10.6084/m9.figshare.7149167). Of these 598 A. fumigatus genes, 407
(68%) had an orthologous gene that was part of an A. fischeri BGC. This level of
conservation of BGC genes (68%) is much lower than the amount of conservation
observed for the rest of the proteome (88%), illustrating the high rate at which fungal
metabolic pathways evolve (41, 42).
We next directly compared the BGCs of the two organisms. An A. fumigatus BGC was
considered conserved in A. fischeri if 90% of its genes were also present in an A.
fischeri BGC and vice versa. We found that only 10/33 A. fumigatus BGCs are conserved
in A. fischeri and only 13/48 A. fischeri BGCs are conserved in A. fumigatus (Fig. 4), a
finding consistent with previous results (39) and the low conservation of individual
secondary metabolic genes between the two species. While only 10 A. fumigatus BGCs
were conserved in A. fischeri, many other BGCs contained one or more orthologs of
genes in A. fischeri BGCs.
Only one BGC (cluster 18) was completely A. fumigatus specific. Interestingly, our
previous examination of the genomes of 66 A. fumigatus strains showed that this BGC
was a “jumping cluster,” as it was found to be present in only 5 strains and to reside in
three distinct genomic locations (42). Conversely, there are 10 A. fischeri-specific BGCs
that do not have orthologs in BGCs in A. fumigatus. One of these BGCs is responsible
for making helvolic acid (a gene cluster known to be absent from the A. fumigatus strain
CEA10 but present in strain Af293 [42]), but the other 9 have not been biochemically
connected to any metabolite.
All the genes required for the production of the mycotoxin gliotoxin are located in
a BGC in A. fischeri (Fig. S4) and are in fact similar to their A. fumigatus orthologs (43),
even though A. fischeri is not known to produce this mycotoxin (44). Both the gliotoxin
and acetylaszonalenin BGCs are adjacent to one another in the A. fischeri genome
(Fig. S4). In A. fumigatus, the gliotoxin BGC is immediately next to what appears to be
a truncated version of the acetylaszonalenin BGC that lacks portions of the nonribo-
somal peptide synthase and acetyltransferase genes as well as the entire indole
prenyltransferase gene required for acetylaszonalenin production. The close proximity
of these two BGCs is noteworthy, as it is similar to previously reported “superclusters”
in A. fumigatus and A. fumigatus-related strains (45). These superclusters have been
hypothesized to be “evolutionary laboratories” that may give rise to new compounds
and pathways (42).
Isolation and characterization of three new compounds from A. fischeri. The
relatively low level of conservation of BGCs we observed between A. fumigatus and A.
fischeri led us to characterize the secondary metabolites produced by A. fischeri (Fig. S5)
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(46–50). The one strain-many compounds (OSMAC) approach was used to alter the
secondary metabolites being biosynthesized in order to produce a diverse set of
molecules (51–54). Depending on the medium on which it was grown, A. fischeri
produced as few as 4 (yeast extract soy peptone dextrose agar [YESD]) or as many as
10 (oatmeal agar [OMA]) compounds (Fig. S6). These results showed that culture
medium influences the biosynthesis of secondary metabolites in A. fischeri, a phenom-
enon observed in many other fungi (52, 55).
To characterize the peaks of interest we observed when A. fischeri was grown on
OMA, we increased the size of our fungal cultures; doing so yielded seven previously
isolated compounds (sartorypyrone A [compound 1], aszonalenin [compound 4], acety-
laszonalenin [compound 5], fumitremorgin A [compound 6], fumitremorgin B [com-
pound 7], verruculogen [compound 8], and the C-11 epimer of verruculogen TR2
[compound 9]) and three newly biosynthesized secondary metabolites (sartorypyrone
E [compound 2], 14-epiaszonapyrone A [compound 3], and 13-O-fumitremorgin B
[compound 10]). Two of the secondary metabolites were new compounds (compounds
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FIG 4 Biosynthetic gene clusters (BGCs) of A. fumigatus and A. fischeri show substantial evolutionary divergence. Predicted BGCs are shown in
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2 and 3), and one was a new natural product (compound 10) (Fig. 5B). The structures
for all 10 compounds were determined using a set of spectroscopic (1D and 2D NMR)
and spectrometric techniques (high-resolution mass spectrometry [HRMS]). Our data for
sartorypyrone A (compound 1) (56), aszonalenin (compound 4) (57, 58), acetylaszon-
alenin (compound 5) (56, 59), fumitremorgin A (compound 6) (60, 61), fumitremorgin B
(compound 7) (62–64), verruculogen (compound 8) (65, 66), and the C-11 epimer of
verruculogen TR2 (compound 9) (66) correlated well with literature values. The struc-
tures of 14-epiaszonapyrone A (compound 3) and 13-O-prenyl fumitremorgin B (com-
pound 10) were fully characterized in this study (see Figshare document at https://doi
.org/10.6084/m9.figshare.7149167); the structure elucidation of sartorypyrone E
(compound 2) is ongoing and will be reported in detail in a forthcoming manuscript.
Since four secondary metabolites (compounds 5 to 8) from A. fischeri had also been
reported from A. fumigatus (Table 2), we hypothesized that the mechanisms A. fischeri
employs to regulate its secondary metabolism would also be similar to those used by
A. fumigatus. To test this hypothesis, we constructed a deletion mutant of laeA in A.
fischeri (Fig. S7). LaeA is a master regulator of secondary metabolism in A. fumigatus and
a variety of other fungi (67–69). Both the wild-type and ΔlaeA strains of A. fischeri were
subjected to LC-MS analysis. The chromatographic profile of the ΔlaeA strain showed
mass data that corresponded to sartorypyrone A (compound 1), sartorypyrone E
(compound 2), 14-epiaszonapyrone A (compound 3), aszonalenin (compound 4), acety-
laszonalenin (compound 5), fumitremorgin A (compound 6), verruculogen (compound
8), and the C-11 epimer of verruculogen TR2 (compound 9). However, the relative
abundance of compounds present was very low compared to the wild type (Fig. 5C).
Fumitremorgin B (compound 7) and 13-O-prenyl-fumitremorgin B (compound 10) were
not produced by the ΔlaeA mutant at all.
DISCUSSION
A. fumigatus is a major human fungal pathogen, yet its close relative A. fischeri is
rarely an agent of human disease. A number of traits that contribute to the virulence
of A. fumigatus have been characterized, but their distribution and potential role in A.
fischeri-mediated disease are largely unknown. In this study, we thoroughly character-
ized A. fischeri (strain NRRL 181) and compared it to A. fumigatus (strain CEA10) for
multiple disease-relevant biological and chemical differences. Our data show that A.
fischeri can grow in a mammalian host but is much less fit and causes a disease
progression quite different than that observed during A. fumigatus infections (Fig. 1 and
2). Future studies will be needed to determine if these differences between A. fischeri
NRRL 181 and A. fumigatus CEA10 are conserved across a range of A. fischeri and A.
fumigatus isolates.
Further investigations revealed that secondary metabolic genes are much less
conserved than genes in the rest of the genome (see Fig. S3 in the supplemental
material), and a chemical analysis of A. fischeri resulted in the identification of both
previously identified and new compounds (Fig. 5). While the BGCs producing secondary
metabolites in A. fischeri and A. fumigatus appear to be quite different, our data suggest
that a master regulator of secondary metabolism in A. fumigatus (laeA) possesses a
similar role in A. fischeri (Fig. 5C). This is consistent with previous observations that the
global regulation of secondary metabolism is conserved but that the underlying BGCs
are not, suggesting that the regulatory circuit involved in Aspergillus secondary me-
tabolism has undergone extensive regulatory rewiring (41). Our analyses are the first to
infer the occurrence of regulatory circuit rewiring in A. fischeri and are among the first
gene knockout studies of this organism (70).
In order to cause disease, a microbe must be able to respond to the set of diverse
and stressful environments presented by its host. Based on our data, A. fischeri strain
NRRL 181 is unable to respond to many of these stresses as well as A. fumigatus CEA10
(Fig. 2 and 3). We hypothesize that this inability to thrive under stress contributes to the
various disease progressions observed during our animal model experiments (Fig. 1).
Some or all of the genetic determinants responsible for this discrepancy in stress
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response and virulence could reside in the 1,200 A. fumigatus-specific genes we
identified (Fig. S3); alternatively, some of the 1,700 A. fischeri-specific genes we
identified may inadvertently facilitate control of A. fischeri in a mammalian host. An
additional explanation for the discrepancy in stress response is that A. fumigatus has
evolved more efficient regulatory circuits than A. fischeri that allow it to cope with more
stringent conditions that are observed in the host.
Even though more than 10% of the genes in each species lack an ortholog in the
other species, only 2% (1/49) of previously identified genetic determinants of viru-
lence in A. fumigatus are not conserved in A. fischeri (see Table S1 in the Figshare
document at https://doi.org/10.6084/m9.figshare.7149167). This result and our obser-
vation that many of the pathways of secondary metabolism are quite different between
A. fischeri and A. fumigatus support a multifactorial model of A. fumigatus virulence
(71–73) and suggest a need to investigate virulence on multiple levels of biological
complexity. In order to cause disease in a host, A. fumigatus (and other species closely
related to it) must adhere and germinate in the lung (73), survive inherently stressful
conditions presented by host environments (e.g., severe lack of metals and oxygen) (5,
74, 75), and modulate or endure actions of the host immune system (76). Given the
diversity of these activities, it is unlikely that single genes or pathways will be respon-
sible for the totality of A. fumigatus-derived disease, even though many genes in the
genome have not yet been characterized for their role in pathogenicity. We hypothe-
size that multiple pathways (including those involved in secondary metabolism) have
changed during the evolution of A. fischeri and A. fumigatus, resulting in their differing
ability to cause disease.
As mentioned, an important caveat to our experiments is that we analyzed only a
single, representative strain from each species, and further studies are needed to
determine how typical these observed trait and genomic differences are across multiple
strains from each species. Several recent studies have identified a wide variety of
differences between A. fumigatus strains, which have in turn been shown to contribute
to physiological differences, including but not limited to secondary metabolism and
virulence (30, 72, 73). While the genome of only one isolate of A. fischeri has so far been
sequenced (16) and the organism has been reported to cause human disease only a few
times (21–24), it would be of great interest to compare patient-derived and
FIG 5 Legend (Continued)
fischeri was initially grown on rice for 2 weeks and then extracted using methods outlined in Fig. S5. The rice culture yielded compounds 1, 4, and 5. (Middle)
A. fischeri was grown on multigrain Cheerios for 2 weeks, which yielded compounds 1 and 4 to 9. (Bottom) A. fischeri grown on Quaker oatmeal for 2 weeks.
All compounds that were previously isolated in rice and multigrain Cheerios cultures in addition to three new compounds (2, 3, and 10) were found in the
oatmeal culture. All pictures depict fungi growing in 250-ml Erlenmeyer flasks; the left panel indicates the top view, while the right panel shows the bottom
view. All chromatographic profiles have been normalized to the highest AU value. (C) A. fischeri wild-type and ΔlaeA strains were grown on solid breakfast
oatmeal for 2 weeks and extracted using organic solvents as indicated previously. The crude desugared and defatted extracts were run using UPLC-MS at
a concentration of 2 mg/ml with 5 l being injected for analysis. The chromatographic profiles were normalized to the highest AU value. Mass
spectrometry analysis indicated the presence of secondary metabolites 1 to 10 within the wild type, and only compounds 1 to 6, 8, and 9 were seen in the
laeA mutant. All pictures show A. fischeri grown on oatmeal agar in petri plates.
TABLE 2 Secondary metabolites isolated from A. fischeri that have been reported from A.
fumigatus
Secondary metabolite (compound no.)
Presence in strain:
A. fischeri A. fumigatus
Sartorypyrone A (1)  	
Sartorypyrone E (2)  	
14-Epiaszonapyrone A (3)  	
Aszonalenin (4)  	
Acetylaszonalenin (5)  
Fumitremorgin A (6)  
Fumitremorgin B (7)  
Verruculogen (8)  
C-11 epimer of verruculogen TR2 (9)  	
13-O-Fumitremorgin B (10)  	
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environment-derived isolates at the genomic, phenotypic, and chemical levels. Al-
though it appears that clinical and environmental isolates do not stem from separate
lineages in A. fumigatus (77), whether this is also the case for largely nonpathogenic
species, such as A. fischeri, or for rarely isolated pathogenic species, such as A. lentulus
or A. udagawae, remains largely unknown.
Our mouse infection studies revealed that A. fischeri strain NRRL 181 was less
virulent than A. fumigatus strain CEA10 in both leukopenic and steroid-induced im-
mune suppression models of disease. The difference in disease outcome in the steroid
model closely matches what was observed in comparisons of two A. fumigatus strains,
CEA10 and Af293 (30). It is intriguing that the difference between pathogenic (A.
fumigatus CEA10) and nonpathogenic (A. fischeri NRRL 181) species in disease outcomes
in this model is similar to that between two clinically derived pathogenic strains (A.
fumigatus CEA10 and Af293). Interestingly, Kowalski et al. (30) did not observe any
statistically significant difference in disease progression between CEA10 and Af293 in
the leukopenic model, whereas we found that A. fischeri is less virulent in this second
murine model of disease (Fig. 1). These strain-, species-, and infection model-specific
differences in disease outcomes are consistent with our hypothesis that A. fumigatus
virulence is a complex genetic trait and highlight the need for further studies using
wider sets of strains, species, and virulence-related traits.
A. fumigatus and A. fischeri are members of Aspergillus section Fumigati, a clade that
includes multiple closely related species, some of which are pathogens (e.g., A. fumiga-
tus, A. lentulus, and A. udagawae) and some of which are considered nonpathogens
(e.g., A. fischeri, A. aureolus, and A. turcosus) (1, 44, 78, 79). The ability to cause disease
in humans appears to have either arisen or been lost (or both) multiple times inde-
pendently during the evolution of this lineage, as pathogenic species are spread
throughout the phylogeny (17, 80). A broader, phylogenetically informed comparison
of pathogenic and nonpathogenic species in section Fumigati would provide far greater
resolution in identifying (or dismissing) factors and pathways that may contribute to or
prevent the ability of these organisms to cause disease. Also, leveraging the diversity of
section Fumigati would give researchers a better understanding of the nature and
evolution of human fungal pathogenesis as the appreciation for the health burden
caused by fungi increases (81).
MATERIALS AND METHODS
Strains and growth media. A. fischeri strain NRRL 181 was acquired from the ARS Culture Collection
(NRRL). A. fumigatus strain CEA10 (CBS 144.89) was obtained from the Westerdijk Fungal Biodiversity
Institute (CBS). All strains were grown on glucose minimal medium (GMM) from conidial glycerol stocks
stored at 	80°C. All strains were grown in the presence of white light at 37°C. Conidia were collected in
0.01% Tween 80 and enumerated with a hemocytometer.
Murine virulence studies. For the chemotherapeutic (leukopenic) murine model, outbred CD-1
female mice (Charles River Laboratories, Raleigh, NC, USA), 6 to 8 weeks old, were immunosuppressed
with intraperitoneal (i.p.) injections of 150 mg/kg (of body weight) cyclophosphamide (Baxter Healthcare
Corporation, Deerfield, IL, USA) 48 h before and 72 h after fungal inoculation, along with subcutaneous
(s.c.) injections of 40 mg/kg triamcinolone acetonide (Kenalog-10; Bristol-Myers Squibb, Princeton, NJ,
USA) 24 h before and 6 days after fungal inoculation. For the murine triamcinolone model, outbred CD-1
female mice, 6 to 8 weeks old, were treated with 40 mg/kg triamcinolone acetonide by s.c. injection 24
h prior to fungal inoculation.
Unless otherwise noted, conidial suspensions of 2  106 conidia were prepared in 40 l sterile PBS
and administered to mice intranasally while under isoflurane anesthesia. Mock mice were given 40 l
PBS. Mice were monitored three times a day for signs of disease for 14 or 18 days postinoculation.
Survival was plotted on Kaplan-Meier curves, and statistical significance between curves was determined
using Mantel-Cox log rank and Gehan-Breslow-Wilcoxon tests. Mice were housed in autoclaved cages at
4 mice per cage with HEPA-filtered air and autoclaved food and water available ad libitum.
Galleria mellonella virulence studies. G. mellonella larvae were obtained by breeding adult moths
(82). G. mellonella larvae of a similar size were selected (approximately 275 to 330 mg) and kept without
food in glass containers (petri dishes) at 37°C in darkness for 24 h prior to use. A. fumigatus and A. fischeri
conidia were obtained by growth on YAG medium for 2 days. The conidia were harvested in PBS and
filtered through Miracloth (Calbiochem). The concentration of conidia was estimated by using a hemo-
cytometer, and conidia were resuspended at a concentration of 2.0  108 conidia/ml. The viability of the
conidia was determined by incubation on YAG medium at 37°C for 48 h. Inocula (5 l) of conidia from
both strains were used to investigate the virulence of A. fumigatus and A. fischeri against G. mellonella.
Ten G. mellonella larvae in the final (sixth) instar larval stage of development were used per condition in
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all assays. The control group was the larvae inoculated with 5 l of PBS to observe the killing due to
physical trauma. The inoculation was performed by using a Hamilton syringe (7000.5KH) and injecting
5 l into the hemocoel of each larva via the last left proleg. Afterward, the larvae were incubated in a
glass container (petri dishes) at 37°C in the dark. Larval killing was scored daily. Larvae were considered
dead by presenting the absence of movement in response to touch.
Histopathology. Outbred CD-1 mice, 6 to 8 weeks old, were immunosuppressed and intranasally
inoculated with 2  106 conidia as described above for the chemotherapeutic and corticosteroid murine
models. Mice were sacrificed 72 h postinoculation. Lungs were perfused with 10% buffered formalin
phosphate before removal and then stored in 10% buffered formalin phosphate until embedding.
Paraffin-embedded sections were stained with hematoxylin and eosin (H&E) and Gomori methenamine
silver (GMS). Slides were analyzed microscopically with a Zeiss Axioplan 2 imaging microscope (Carl Zeiss
Microimaging, Inc., Thornwood, NY, USA) fitted with a QImaging Retiga-SRV Fast 1394 RGB camera.
Analysis was performed in Phylum Live 4 imaging software.
Ethics statement. We carried out our mouse studies in strict accordance with the recommendations
in the Guide for the Care and Use of Laboratory Animals of the National Research Council (83). The mouse
experimental protocol was approved by the Institutional Animal Care and Use Committee (IACUC) at
Dartmouth College (Federal-wide assurance number A3259-01).
Growth assays. Radial growth was quantified by point inoculation of 1  103 conidia in 2 l on
indicated media; plates were incubated at 37°C in normoxia (21% O2, 5% CO2) or hypoxia (0.2% O2, 5%
CO2). Colony diameter was measured every 24 h for 4 days and reported as the average from three
biological replicates per strain.
For 2-DG experiments, 1  103 conidia in 2 l were spotted on 1% lactate minimal medium with or
without 0.1% 2-deoxyglucose (2-DG; Sigma, D8375). Plates were incubated for 3 days at 37°C in normoxia
or hypoxia with 5% CO2. Percent inhibition was calculated by dividing radial growth on 2-DG plates by
the average radial growth of biological triplicates on plates without 2-DG.
Fungal biomass was quantified by measuring the dry weight of fungal tissue from 5  107 conidia
grown in 100 ml liquid GMM with shaking at 200 rpm for 48 h in normoxia (21% O2) and hypoxia (0.2%
O2, 5% CO2). Liquid biomass is reported as the average from three biological replicates per strain. Hypoxic
conditions were maintained using an InvivO2 400 hypoxia workstation (Ruskinn Technology Limited,
Bridgend, United Kingdom) with a gas regulator and 94.8% N2.
Liquid growth curves were performed with conidia adjusted to 2  104 conidia in 20 l 0.01% Tween
80 in 96-well dishes, and then 180 l of medium (GMM or lung homogenate) was added to each well.
Plates were incubated at 37°C for 7 h, and then A405 measurements were taken every 10 min for the first
16 h of growth with continued incubation at 37°C. Lung homogenate medium was prepared as follows:
lungs were harvested from healthy CD-1 female mice (20 to 24 g) and homogenized through a 100-m
cell strainer in 2 ml PBS/lung. Homogenate was diluted 1:4 in sterile PBS, spun down to remove cells, and
then filter sterilized through 22-m PVDF filters.
Cell wall and oxidative stresses. Congo red (0.5 mg/ml), menadione (20 M), or calcofluor white
(CFW; 25 g/ml) was added to GMM plates. Conidia at 1  103 (calcofluor white and menadione) or
1  105 (Congo red) were point inoculated, and plates were incubated for 96 h at 37°C with 5% CO2.
Orthology determination and analyses. Genomes for A. fumigatus CEA10 and A. fischeri NRRL 181
were downloaded from NCBI (accession numbers GCA_000150145.1 and GCF_000149645.1, respec-
tively). To identify putative orthologous genes between A. fischeri and A. fumigatus, a reciprocal best
BLAST hit (RBBH) approach was used. We performed a BLAST search on the proteome of A. fischeri to A.
fumigatus and vice versa using an E value cutoff of 10	3 and then filtered for RBBHs according to bitscore
(84). A pair of genes from each species was considered orthologous if their best BLAST hit was to each
other. Species-specific and orthologous protein sets were visualized using version 3.0.0 of eulerAPE (85).
Biosynthetic gene cluster (BGC) prediction and analyses. Version 4.2.0 of antiSMASH (40) was
used with its default settings to identify BGCs. Orthologous cluster genes were identified using our RBBH
results and visualized using version 0.69 of Circos (86). Chromosomes were identified for A. fischeri NRRL1
and A. fumigatus CEA10 using NUCMER (87) and chromosomal sequences from A. fumigatus strain AF293
from NCBI (accession number GCA_000002655.1). Syntenic clusters were visualized using Easyfig version
2.2.2 (88).
Secondary metabolite extraction and identification. Secondary metabolites were extracted from
A. fischeri using techniques well established in the natural product literature (89, 90). This was done by
adding a 1:1 mixture of CHCl3-CH3OH and leaving the mixture to shake overnight. The resulting slurry
was partitioned twice, first with a 4:1:5 CHCl3-CH3OH-H2O solution, with the organic layer drawn off and
evaporated to dryness in vacuo, and second, reconstituting 1:1:2 CH3CN-CH3OH-hexanes, where the
organic layer was drawn off and evaporated to dryness. The extract then underwent chromatographic
separation (flash chromatography and HPLC) using varied gradient systems. The full structural charac-
terization of the new secondary metabolites is provided in a Figshare document (https://doi.org/10.6084/
m9.figshare.7149167).
Construction of the A. fischeri laeA mutant. The gene replacement cassettes were constructed by
in vivo recombination in Saccharomyces cerevisiae as previously described (91, 92). Approximately 2.0 kb
from the 5=-UTR and 3=-UTR flanking regions of the targeted ORF were selected for primer design. The
primers pRS NF010750 5=fw (5=-GTAACGCCAGGGTTTTCCCAGTCACGACGCAGTCTAACGCTGGGCCCTTCC-
3=) and pRS NF010750 3=rv (5=-GCGGTTAACAATTTCTCTCTGGAAACAGCTACGGCGTTTGACGGCACAC-3=)
contained a short homologous sequence to the multicloning site (MCS) of the plasmid pRS426. Both the
5=- and 3=-UTR fragments were PCR amplified from A. fischeri genomic DNA (gDNA). The prtA gene,
conferring resistance to pyrithiamine, which was placed within the cassette as a dominant marker, was
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amplified from the pPRT1 plasmid by using the primers prtA NF010750 5=rv (5=-GTAATCAATTGCCCGTC
TGTCAGATCCAGGTCGAGGAGGTCCAATCGG-3=) and prtA NF010750 3=fw (5=-CGGCTCATCGTCACCCCATG
ATAGCCGAGATCAATCTTGCATCC-3=). The deletion cassette was generated by transforming each frag-
ment along with the plasmid pRS426, cut with BamHI/EcoRI, into the S. cerevisiae strain SC94721 using
the lithium acetate method (93). The DNA from the transformants was extracted by the method
described by Goldman et al. (94). The cassette was PCR amplified from these plasmids utilizing TaKaRa
Ex Taq DNA polymerase (Clontech TaKaRa Bio) and used for A. fischeri transformation according to the
protocol described by Malavazi and Goldman (92). Southern blotting and PCR analyses were used to
demonstrate that the cassette had integrated homologously at the targeted A. fischeri locus. Genomic
DNA from A. fischeri was extracted by grinding frozen mycelia in liquid nitrogen, and then gDNA was
extracted as previously described (92). Standard techniques for manipulation of DNA were carried out as
described previously (95). For Southern blot analysis, restricted chromosomal DNA fragments were
separated on a 1% agarose gel and blotted onto Hybond N nylon membranes (GE Healthcare). Probes
were labeled using [-32P]dCTP using the Random Primers DNA labeling system (Life Technologies).
Labeled membranes were exposed to X-ray films, which were scanned for image processing. Southern
blotting and PCR schemes are shown in Fig. S7 in the supplemental material.
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